Stockscreener 앱 받기
0.86
1.37%
+0.0116
시간 외 거래:
.8735
0.0135
+1.57%
전일 마감가:
$0.8484
열려 있는:
$0.882
하루 거래량:
370.81K
시가총액:
$104.16M
수익:
$46.74M
순이익/손실:
$-114.33M
주가수익비율:
-1.4305
EPS:
-0.6012
순현금흐름:
$-21.04M
1주 성능:
-2.33%
1개월 성능:
-44.16%
6개월 성능:
-47.56%
1년 성능:
-84.36%
1일 변동 폭
$0.8401
$0.8929
52주 변동 폭
$0.8002
$8.3699
Scilex Holding Company Stock (SCLX) Company Profile
명칭
Scilex Holding Company
전화
650-516-4310
주소
960 San Antonio Road, Palo Alto
Scilex Holding Company 주식(SCLX)의 최신 뉴스
Scilex Holding Company Announces Closing of $15 Million Registered Direct Offering
GlobeNewswire Inc.
Scilex Holding Company Announces $15 Million Registered Direct Offering
GlobeNewswire Inc.
Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool
GlobeNewswire Inc.
Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients
GlobeNewswire Inc.
Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®
GlobeNewswire Inc.
Scilex Holding Announces Issuance of Halal Certification for its ZTlido® product by Circle H International, Inc.
GlobeNewswire Inc.
Scilex Holding Company (SCLX) 재무 분석
Scilex Holding Company (SCLX) 매출 2024
SCLX은 2023-12-31 종료 분기에 대해 매출(지난 12개월)이 46.74M 달러로 보고했으며, 전년대비 +22.90% 상승했습니다.
Scilex Holding Company (SCLX) 순이익 2024
SCLX은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -114.33M 달러로 보고했으며, 전년대비 -389.35% 감소했습니다.
Scilex Holding Company (SCLX) 현금흐름 2024
2023-12-31 종료 분기에 SCLX은 현금흐름(지난 12개월)으로 -21.04M 달러를 기록했으며, 전년 대비 +1.04% 증가했습니다.
Scilex Holding Company (SCLX) 주당 순이익 2024
SCLX이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -1.29달러이며, 전년 대비 -646.53% 감소했습니다.
0.35%
0.91%
자본화:
|
볼륨(24시간):